If you have been reading about preclinical research and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-08-01. Numbers and descriptions here follow the published literature rather than marketing material.
Development of dihexa followed from studies on angiotensin IV analogs and their effects on learning and memory. Researchers sought compounds with improved metabolic stability and brain penetration compared with natural peptides. In preclinical reports, dihexa was associated with changes in synaptic connectivity and performance on spatial tasks. These findings generated interest in its potential as a cognitive research tool. The work remains largely preclinical, and independent replication has been limited.
Regulatory and commercial contexts differ from clinical medicine. Dihexa is not approved as a drug by major agencies, and no published human trials establish its safety or efficacy. It is often sold as a research chemical labeled for laboratory use only. Suppliers may provide certificates of analysis, but purity and identity depend on the specific batch. Legal status varies by country and may treat such compounds as unapproved substances for human consumption.
Dihexa is a synthetic peptidomimetic derived from angiotensin IV, a naturally occurring peptide fragment. It was created as a research compound to explore central nervous system signaling rather than as an approved therapeutic. Early work described it as a small, orally available molecule in rodent studies. Its structure combines tyrosine, isoleucine, and aminohexanoic acid components with a hexanoic acid cap. The compound is commonly referred to by the research code PNB-0408.
Human safety data are sparse. No widely accepted dosing regimen, long-term safety profile, or clinical efficacy endpoint has been established. Published animal results can suggest directions for further study, but species differences and study design limit direct translation. Open questions include bioavailability, blood-brain barrier penetration, metabolism, and whether observed effects arise from a single target or multiple pathways. Replication across independent laboratories remains an important benchmark for evaluating the strength of preclinical claims.
Most published reports on dihexa come from cell cultures and animal models. Studies have examined markers of synapse formation, dendritic spine density, and performance on learning tasks in rodents. Proposed mechanisms center on hepatocyte growth factor and its c-Met receptor, with additional attention to angiotensin IV-related pathways. These findings are experimental and have not been confirmed as clinical benefits in humans. The literature often uses different tasks and endpoints, which complicates direct comparison across studies.
| Property | Value | Notes |
|---|---|---|
| Chemical class | Synthetic angiotensin IV analog | Peptidomimetic |
| Appearance | White to off-white powder | Lyophilized solid |
| Solubility | Soluble in DMSO; limited in water | Typical for small peptides |
| Storage | -20 °C, desiccated | Protect from light and moisture |
| Analytical method | HPLC with UV detection | Purity and identity checks |
Regulatory agencies have not approved dihexa as a prescription drug or supplement. In many countries it falls into a gray area when sold for laboratory research. Buyers may encounter products marketed for research use only, which are not intended for human consumption. Purity and identity can vary between suppliers and batches. Certificates of analysis and independent testing are often recommended for research materials. Documentation helps verify what a vial contains.
Discussion of dihexa in online communities sometimes outpaces the scientific record. Anecdotal reports are difficult to verify and may not distinguish effects from placebo or expectation. The absence of approved human data means long-term risks remain unknown. Researchers continue to investigate related compounds and pathways. Open questions include whether animal findings translate to humans and which biological targets matter most. No consensus exists on these points. Current reviews emphasize the need for rigorous clinical research.
Dihexa is a synthetic peptide studied in preclinical neuroscience. It is often described as an angiotensin IV analog or derivative. The compound also appears under research codes such as PNB-0408 and N-hexanoic-Tyr-Ile-(6)-aminohexanoic amide. It is not an approved drug, and it is not a conventional vitamin or nutrient. In many jurisdictions, material sold as dihexa is handled as a research chemical rather than a medicine or supplement. This classification affects how the material is labeled and distributed.
Chemically, dihexa is a short peptide-like molecule with nonstandard components. Its structure includes tyrosine and isoleucine residues linked to a hexanoic acid group and an aminohexanoic amide segment. This design distinguishes it from endogenous angiotensin IV, though the two are discussed together because of shared origins. Published summaries classify it as a small synthetic peptide with lipophilic features that may influence how it crosses biological barriers in experimental systems. Exact conformational details depend on the specific salt or free base form.
The proposed mechanism for dihexa centers on hepatocyte growth factor, or HGF, and its receptor c-Met. HGF signaling is involved in cell growth, survival, and synapse formation. Dihexa has been described as an HGF mimetic or modulator in preclinical literature. Whether it binds c-Met directly, increases HGF availability, or acts through another route remains uncertain. This mechanistic uncertainty is a recurring theme in reviews of the compound, and no single molecular model has been confirmed across independent laboratories.
Research on dihexa has primarily used rodent models and cultured cells. Common endpoints include dendritic spine density, synaptic protein expression, and performance on maze or avoidance tasks. Some studies report improvements in cognitive measures after scopolamine-induced deficits or in aged animals. These findings are interesting but come from a small body of work, and independent laboratories have not consistently replicated all reported effects. Larger, preregistered studies would help clarify which results are robust.
Human data for dihexa remain absent from peer-reviewed clinical literature. As a result, questions about absorption, distribution, metabolism, excretion, and long-term safety are unresolved. Discussions often appear in nootropic forums, where anecdotal reports cannot substitute for controlled trials. Researchers have called for more rigorous pharmacokinetic and toxicological studies before any clinical evaluation. Until such data exist, dihexa is best described as an investigational research compound rather than a proven intervention.
Dissolution depends on the peptide’s salt form, purity, and the chosen solvent. Dimethyl sulfoxide is commonly used to prepare concentrated stock solutions, while aqueous buffers may show limited solubility. Sonication or gentle warming can sometimes aid dissolution, but excessive heat may promote degradation. Once in solution, the material is generally kept cold and protected from light. Researchers should verify solubility for each lot rather than assuming uniform behavior across suppliers.
Quality control usually combines reverse-phase high-performance liquid chromatography with mass spectrometry. Chromatography estimates purity and detects related impurities, while mass spectrometry supports molecular identity. Nuclear magnetic resonance can provide additional structural confirmation when needed. Stability data for dihexa are limited, and degradation pathways may depend on pH, temperature, and moisture. Open questions include long-term stability in different formulations and the effect of repeated freeze-thaw cycles on measured purity. Such tests help confirm that a batch matches its label before use.
== History == The use of generative artificial intelligence to create sexually explicit images emerged in 2022 on platforms such as Reddit and 4chan. AI-generated pornography became widespread in the early 2020s following Stability AI's release of Stable Diffusion (SD). This open-source model enables the creation of images from text prompts, utilizing the LAION-5B dataset. Following the model's public release, the volume of both explicit and non-explicit AI-generated media content increased. Due to the open-source nature of Stable Diffusion, there were no restrictions on image generation, which led to controversies regarding open-access AI and its use in generating explicit content. Over time, open-source AI models improved, enabling the creation of highly realistic images and intensifying calls for regulation in this area.
(2026) report evidence of greater similarity of the vertebral apophyseal ring of Lucy (and likely spinal biomechanics of the studied individual) to those of extant African apes than to those of modern humans, and interpret this finding as indicative of emergence of fully modern human gait later in the hominin evolution. Hatala et al. (2026) describe approximately 1.43-million-years-old hominin footprints from northern Kenya produced by a group that included multiple adult males, preserving a morphology similar to footprints attributed to Paranthropus boisei, but produced by hominins larger than known representatives of that species. Evidence indicating that the evolution cranial morphological variation in members of the genus Homo was primarily influenced by selective constraints, their releases and by stabilizing selection rather than by gradual directional selection is presented by Hubbe & Harvati (2026). Blasi-Toccacceli et al. (2026) describe fossil material of a 1.84-million-years-old member of the genus Homo from the Shungura Formation (Ethiopia), including the oldest well-preserved shoulder and arm bones of a member of this genus, interpreted as indicative of reduction of use of arms in arboreal locomotion early in the evolution of Homo. The most complete skeleton of Homo habilis reported to date is described from the upper Burgi Member of the Koobi Fora Formation (Kenya) by Grine et al. (2026).
=== 21st century === About 89 percent of vehicular fuel needs are met by oil. Petroleum makes up 38 percent of total energy consumption in the United States, but is responsible for only 0.4 percent of electricity generation. Petroleum's worth as a portable, dense energy source powering the vast majority of vehicles and as the base of many industrial chemicals makes it one of the world's most important commodities. The top three oil-producing countries as of 2018 are the United States, Russia, and Saudi Arabia. In 2018, due in part to developments in hydraulic fracturing and horizontal drilling, the United States became the world's largest producer. About 80 percent of the world's readily accessible reserves are located in the Middle East, with 62.5 percent coming from the Arab five: Saudi Arabia, United Arab Emirates, Iraq, Qatar, and Kuwait. A large portion of the world's total oil exists as unconventional sources, such as bitumen in Athabasca oil sands and extra heavy oil in the Orinoco Belt. While significant volumes of oil are extracted from oil sands, particularly in Canada, logistical and technical hurdles remain, as oil extraction requires large amounts of heat and water, making its net energy content quite low relative to conventional crude oil. Thus, Canada's oil sands are not expected to provide more than a few million barrels per day in the foreseeable future. Many modern geopolitical conflicts are to do with petroleum.
=== Colonial Police Medal (CPM) === Chan Pak-chi, Superintendent, Royal Hong Kong Police Force. Albert Chan Ting-kai, Senior Divisional Officer, Royal Hong Kong Police Force. Chan Yun-pui, Senior Divisional Officer, Royal Hong Kong Police Force. Cheung Yuk-fung, Superintendent, Royal Hong Kong Police Force. Paul Croft, Senior Superintendent, Royal Hong Kong Police Force. William Frederick Fenton, Senior Superintendent, Royal Hong Kong Police Force. Gillian Suk-han Fletcher, Chief Inspector, Royal Hong Kong Police Force. Fu Keung San-ling, Sergeant, Royal Hong Kong Police Force. Barry Christopher Griffin, Senior Superintendent, Royal Hong Kong Police Force. Tony Ho Tse-tong, Senior Superintendent, Royal Hong Kong Police Force. Victor Hsu Yung, Senior Divisional Officer, Royal Hong Kong Police Force. Kwan Wa-fai, Station Sergeant, Royal Hong Kong Police Force. Lee Yeung-chi, Superintendent, Royal Hong Kong Police Force. Leung Ping, Station Sergeant, Royal Hong Kong Police Force. Li Chun-wai, Station Sergeant, Royal Hong Kong Police Force. Li Kam-wa, Station Sergeant, Royal Hong Kong Police Force. Li Mau-sau, Station Sergeant, Royal Hong Kong Police Force. Liu Tin-chee, Senior Divisional Officer, Royal Hong Kong Police Force. Lo Chan Lin, Station Sergeant, Royal Hong Kong Police Force. Kenneth William Colin Mackenzie, Superintendent, Royal Hong Kong Police Force. Edward Mak Man-poon, Senior Superintendent, Royal Hong Kong Police Force. Martin Samson, Senior Superintendent, Royal Hong Kong Police Force. Tam Sum-wing, Station Sergeant, Royal Hong Kong Police Force.
=== Rare reactions === Aside from hyperkalemia, spironolactone may rarely cause adverse reactions such as anaphylaxis, kidney failure, hepatitis (two reported cases, neither serious), agranulocytosis, DRESS syndrome, Stevens–Johnson syndrome, or toxic epidermal necrolysis. Five cases of breast cancer in patients who took spironolactone for prolonged periods of time have been reported.
Sources: en.wikipedia.org
== Structure == ATP consists of three parts: a sugar, an amine base, and a phosphate group. More specifically, ATP consists of an adenine attached by the #9-nitrogen atom to the 1′ carbon atom of a sugar (ribose), which in turn is attached at the 5' carbon atom of the sugar to a triphosphate group. In its many reactions related to metabolism, the adenine and sugar groups remain unchanged, but the triphosphate is converted to di- and monophosphate, giving respectively the derivatives ADP and AMP. The three phosphoryl groups are labeled as alpha (α), beta (β), and, for the terminal phosphate, gamma (γ). In neutral solution, ionized ATP exists mostly as ATP4−, with a small proportion of ATP3−.
A new Familia 1000 coupé arrived in November 1965, with a 985 cc SOHC "PC" engine, and was joined by the larger Mazda Luce in 1966. Around the same time, the 800 engine was upgraded, adding three horsepower. As a number of new 1-litre vehicles were introduced by Mazda's competitors, another 987 cc OHV engine (PB) appeared in January 1967, powering new 1000 saloon and van versions. The 1-litre saloons and vans are recognizable by their broader, rounded-off rectangular headlights. Production of the saloon continued until November 1967, while the van versions continued until they were replaced in February 1968. Around 400,000 of the first Familias were built, 130,473 of which were saloons and coupés. Around 10,000 of the first generation Familias were exported, mainly to Australia and Oceania.
=== Ca–Ce === David S. Cafiso (b. 1952). American biochemist at the University of Virginia, with research focusing on membranes and membrane proteins. Graham Cairns-Smith FRSE (1931–2016) Scottish organic chemist and molecular biologist at the University of Glasgow. John Cairns FRS (1922–2018) was a British physician and molecular biologist at the Harvard School of Public Health. T. Colin Campbell (b. 1934). American biochemist at Cornell University, specializing in the effect of nutrition on long-term health. David E. Cane (b. 1944). American biological chemist at Brown University, recognized for his work on the biosynthesis of natural products, particularly terpenoids and polyketides. Lewis C. Cantley (b. 1949). American cell biologist and biochemist at Harvard Medical School, who has made significant advances to the understanding of cancer metabolism. Member Natl. Acad. Sci. USA. Charles Cantor (b. 1942). American biophysicist at Boston University, he developed the method of pulse field gel electrophoresis, and was formerly Director of the Human Genome Project. He is known also for his book series Biophysical Chemistry with Paul Schimmel John Carbon (PhD 1955). American cellular biologist at UC Santa Barbara, known for development of techniques for making genome libraries. Member Natl. Acad. Sci. USA. María Luz Cárdenas (b. 1944). French biochemist of Chilean origin at the CNRS, Marseille, known for work on mammalian hexokinases. H. E. Carter (1910–2007). American biochemist, at the University of Illinois, known for determining the structure of threonine. Member Natl.
Mils and strecks are small units of angle used by various military organizations for range estimation and translating map coordinates used for directing artillery fire. The exact size varies between different organizations: there are 6400 NATO mils per turn (1 NATO mil = 0.982 mrad), or 6000 Warsaw pact mils per turn (1 Warsaw pact mil = 1.047 mrad). In the Swedish military, there are 6300 strecks per turn (1 streck = 0.997 mrad).
Sources: en.wikipedia.org
Roughly speaking, high sequence identity suggests that the sequences in question have a comparatively young most recent common ancestor, while low identity suggests that the divergence is more ancient. This approximation, which reflects the "molecular clock" hypothesis that a roughly constant rate of evolutionary change can be used to extrapolate the elapsed time since two genes first diverged (that is, the coalescence time), assumes that the effects of mutation and selection are constant across sequence lineages. Therefore, it does not account for possible differences among organisms or species in the rates of DNA repair or the possible functional conservation of specific regions in a sequence. (In the case of nucleotide sequences, the molecular clock hypothesis in its most basic form also discounts the difference in acceptance rates between silent mutations that do not alter the meaning of a given codon and other mutations that result in a different amino acid being incorporated into the protein.) More statistically accurate methods allow the evolutionary rate on each branch of the phylogenetic tree to vary, thus producing better estimates of coalescence times for genes.
=== Selection for Tavistock === In March 1965, Heseltine applied to be candidate for the safe Conservative seat of Tavistock in Devon, where the incumbent MP had announced his retirement two months earlier. Of the 51 applicants, 14 were considered, six of whom had local connections. Heseltine reached the final short list of three, the others being a dairy farmer in a senior position at the Milk Marketing Board (thought to be the favourite), and a local authority lawyer, who later recalled that on the train down from London Heseltine kept jumping out at every stop to check that his magazines were on display at the station newsagents. Heseltine had already spent several days driving round talking to locals and had ordered a year's worth of back copies of Tavistock's two weekly papers. Such effort is nowadays common in Parliamentary selections but was unusual at the time. He was selected by a clear majority of the Tavistock Conservative Association's Finance and General Purposes Committee (which contained between 100 and 120 people). Heseltine was picked in part as a young, dynamic candidate who could face the challenge of the resurgent Liberal Party in the West Country, where Jeremy Thorpe, Peter Bessell and Mark Bonham Carter had recently won seats. The Liberals had halved the Conservative majority at Tavistock in 1964. Trouble then arose at his adoption by a full general meeting of the Conservative Association, which should have been a formality.
Pea protein is rich in nutrients such as protein and carbohydrates. Pea protein also contains vitamins and minerals and is low in fat. While generally rich in protein, the actual protein content of peas is variable and influenced by both genetic factors and environmental factors (such as soil and climate in which the peas are cultivated). Typically, peas contain 23.1–30.9% protein, 1.5–2.0% fat, and minor constituents such as vitamins, phytic acid, saponins, polyphenols, minerals, and oxalates. They also contain several classes of protein: globulin, albumin, prolamin, and glutelin. The proteins are mainly albumins and globulins, which account for 10-20% and 70-80% of the protein in the pea seed, respectively. The albumins are water-soluble and considered the metabolic and enzymatic proteins, while the globulins are salt soluble and act as the storage proteins for the seed. Globulins can be further classified into legumin and vicilin, which belong to the 11S and 7S seed storage protein classes, respectively. Legumin is a hexameric protein, and vicilin proteins are trimers. Pea protein is considered to be a complete protein, containing all the essential amino acids. However, it is not balanced, as it has high levels of lysine and threonine but relatively low amounts of sulfur-containing amino acids including cysteine and methionine. Pea seeds contain 60-65% carbohydrates mainly composed of oligosaccharides, monosaccharides, polysaccharides, and disaccharides. The major carbohydrate fraction in peas is starch, which is the major storage carbohydrate in the cotyledons.
Sources: en.wikipedia.org
Dihexa is a synthetic peptidomimetic related to angiotensin IV. It is studied in preclinical research for effects on synaptic signaling and cognition. It is not an approved medication.
No major drug regulatory agency has approved dihexa for human use. Published human clinical trials are absent, so its safety and efficacy are not established. It is commonly sold for laboratory research only.
It was developed from research on angiotensin IV analogs and peptide stability. The goal was to find compounds with better brain penetration and metabolic resistance. Early studies used rodent models rather than human participants.
Published human clinical trial data are limited or absent. Most available evidence comes from laboratory and animal studies. Human safety and efficacy remain unresolved.